REGISTERED
on 26 Nov 2024
Last Applicant/ Owned by
Bay & Deveaux Streets
Nassau
BS
0
Serial Number
98369302 filed on 22nd Jan 2024
Registration Number
7578462 registered on 26th Nov 2024
Correspondent Address
Patrick J. Jennings
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
NYMOX
Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Testing of pharmaceuticals; Medical and scientific research in the field of protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, assays, benign prostatic hyperplasia, and prostate cancer
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Testing of pharmaceuticals; Medical and scientific research in the field of protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, assays, benign prostatic hyperplasia, and prostate cancer
First Use Date in General
30th Apr 2007
First Use Date in Commerce
30th Apr 2007
Mark Details
Serial Number
No 98369302
Mark Type
No Service Mark
Attorney Docket Number
No 63307-578488
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Nov 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 26th Nov 2024 | REGISTERED-PRINCIPAL REGISTER |
| 18th Sep 2024 | WITHDRAWN FROM ISSUE - OG REVIEW QUERY |
| 09th Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Jul 2024 | PUBLISHED FOR OPPOSITION |
| 19th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 30th May 2024 | ASSIGNED TO EXAMINER |
| 30th May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 22nd May 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 22nd Jan 2024 | NEW APPLICATION ENTERED |